Duan YC - Search Results

1

Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy.

Duan YC, Zhang SJ, Shi XJ, Jin LF, Yu T, Song Y, Guan YY. Duan YC, et al. Eur J Med Chem. 2021 Oct 15;222:113588. doi: 10.1016/j.ejmech.2021.113588. Epub 2021 Jun 1. Eur J Med Chem. 2021. PMID: 34107385 Review.

2

Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.

Duan YC, Ma YC, Zhang E, Shi XJ, Wang MM, Ye XW, Liu HM. Duan YC, et al. Eur J Med Chem. 2013 Apr;62:11-9. doi: 10.1016/j.ejmech.2012.12.046. Epub 2013 Jan 4. Eur J Med Chem. 2013. PMID: 23353743

3

Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids.

Duan YC, Zheng YC, Li XC, Wang MM, Ye XW, Guan YY, Liu GZ, Zheng JX, Liu HM. Duan YC, et al. Eur J Med Chem. 2013 Jun;64:99-110. doi: 10.1016/j.ejmech.2013.03.058. Epub 2013 Apr 6. Eur J Med Chem. 2013. PMID: 23644193

4

Stereoselective synthesis and anti-proliferative effects on prostate cancer evaluation of 5-substituted-3,4-diphenylfuran-2-ones.

Liu GZ, Xu HW, Wang P, Lin ZT, Duan YC, Zheng JX, Liu HM. Liu GZ, et al. Among authors: duan yc. Eur J Med Chem. 2013 Jul;65:323-36. doi: 10.1016/j.ejmech.2013.04.062. Epub 2013 May 14. Eur J Med Chem. 2013. PMID: 23735281

5

Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.

Zheng YC, Duan YC, Ma JL, Xu RM, Zi X, Lv WL, Wang MM, Ye XW, Zhu S, Mobley D, Zhu YY, Wang JW, Li JF, Wang ZR, Zhao W, Liu HM. Zheng YC, et al. Among authors: duan yc. J Med Chem. 2013 Nov 14;56(21):8543-60. doi: 10.1021/jm401002r. Epub 2013 Nov 1. J Med Chem. 2013. PMID: 24131029 Free PMC article.

6

Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation.

Duan YC, Guan YY, Zhai XY, Ding LN, Qin WP, Shen DD, Liu XQ, Sun XD, Zheng YC, Liu HM. Duan YC, et al. Eur J Med Chem. 2017 Jan 27;126:246-258. doi: 10.1016/j.ejmech.2016.11.035. Epub 2016 Nov 16. Eur J Med Chem. 2017. PMID: 27888721

7

Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.

Duan YC, Ma YC, Qin WP, Ding LN, Zheng YC, Zhu YL, Zhai XY, Yang J, Ma CY, Guan YY. Duan YC, et al. Eur J Med Chem. 2017 Nov 10;140:392-402. doi: 10.1016/j.ejmech.2017.09.038. Epub 2017 Sep 21. Eur J Med Chem. 2017. PMID: 28987602

8

Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.

Duan Y, Qin W, Suo F, Zhai X, Guan Y, Wang X, Zheng Y, Liu H. Duan Y, et al. Bioorg Med Chem. 2018 Dec 15;26(23-24):6000-6014. doi: 10.1016/j.bmc.2018.10.037. Epub 2018 Oct 29. Bioorg Med Chem. 2018. PMID: 30448189

9

Targeting Brd4 for cancer therapy: inhibitors and degraders.

Duan Y, Guan Y, Qin W, Zhai X, Yu B, Liu H. Duan Y, et al. Medchemcomm. 2018 Aug 7;9(11):1779-1802. doi: 10.1039/c8md00198g. eCollection 2018 Nov 1. Medchemcomm. 2018. PMID: 30542529 Free PMC article. Review.

10

Investigating the Binding Mode of Reversible LSD1 Inhibitors Derived from Stilbene Derivatives by 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulation.

Xu Y, He Z, Yang M, Gao Y, Jin L, Wang M, Zheng Y, Lu X, Zhang S, Wang C, Zhao Z, Zhao J, Gao Q, Duan Y. Xu Y, et al. Molecules. 2019 Dec 6;24(24):4479. doi: 10.3390/molecules24244479. Molecules. 2019. PMID: 31817721 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters